Lonza EasyDiff supplements for bone marrow CD34+
Primary human bone marrow hematopoietic progenitors are multipotent cells that can differentiate into several lineages. EasyDiff supplements allow differentiation of CD34+ cells into three different hematopoietic lineages (myeloid, erythroid and megakaryocytic) in 96-well plates.
Users simply add the appropriate volume of media (LGM-3 or IMDM) to dilute the supplement and mix with CD34+ cells in media. Once plated into 96-well plates differentiation will be complete in 10-12 days.
There is no need for methylcellulose or any substrate. Users can verify differentiation via quantification of the expression of lineage-specific markers.
The supplements are suitable for both drug discovery and toxicology research.
Phone: 1300 657508
Bioss In Vivo Biosimilar Antibodies
Bioss In Vivo Biosimilar Antibodies are research-grade copies of therapeutic antibodies that are...
LSBio virology research products
LSBio offers antibodies, proteins, ELISA kits, assay kits and chemical compounds used by...
Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates
The products provide research flow cytometry labs with a low-noise solution, including single...
Learn More
I am interested in Lonza EasyDiff supplements for bone marrow CD34+.
Complete the form and a supplier representative will be in touch.
